Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of 3.39 is 242% above its 5-year average of -2.38, near the high end of its 5-year range (-7.06–3.39).
306.71% above its 12-month average of -1.64.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): 1.98.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T14:38:18.549Z. Historical observations retain their original dates. Historical series through 2026-10-05.
EARNINGS PER SHARE (EPS)
3.39
EARNINGS PER SHARE (EPS) AVG TTM
-1.64
EARNINGS PER SHARE (EPS) AVG 3Y
-1.14
EARNINGS PER SHARE (EPS) AVG 5Y
-2.38
EARNINGS PER SHARE (EPS) AVG 10Y
-2.32
EARNINGS PER SHARE (EPS) AVG 15Y
-0.96
EARNINGS PER SHARE (EPS) AVG 20Y
-0.77
CURRENT VS TTM AVG
+306.71%
CURRENT VS 3Y AVG
+397.37%
CURRENT VS 5Y AVG
+242.24%
CURRENT VS 10Y AVG
+245.87%
CURRENT VS 15Y AVG
+453.62%
CURRENT VS 20Y AVG
+542.56%
LivaNova PLC
Market Cap
$4.12B
Earnings Per Share (EPS)
3.39
TTM Avg
-1.64
3Y Avg
-1.14
5Y Avg
-2.38
Market Cap
$4.03B
Earnings Per Share (EPS)
-0.54
TTM Avg
-0.52
3Y Avg
-0.25
5Y Avg
0.00
Market Cap
$4.25B
Earnings Per Share (EPS)
-1.85
TTM Avg
-1.54
3Y Avg
-1.48
5Y Avg
-1.19
Market Cap
$3.95B
Earnings Per Share (EPS)
1.18
TTM Avg
-2.40
3Y Avg
-2.29
5Y Avg
-0.02
Market Cap
$4.38B
Earnings Per Share (EPS)
2.79
TTM Avg
0.85
3Y Avg
0.10
5Y Avg
0.11
Market Cap
$4.38B
Earnings Per Share (EPS)
-1.42
TTM Avg
-1.45
3Y Avg
-1.45
5Y Avg
-1.45
Market Cap
$4.51B
Earnings Per Share (EPS)
-0.41
TTM Avg
-0.74
3Y Avg
-1.01
5Y Avg
-1.11
Market Cap
$4.62B
Earnings Per Share (EPS)
-3.43
TTM Avg
-1.80
3Y Avg
-1.89
5Y Avg
-2.15
Market Cap
$4.64B
Earnings Per Share (EPS)
0.13
TTM Avg
-0.06
3Y Avg
-0.31
5Y Avg
-0.46
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| LivaNova PLC (LIVN) | $4.12B | 3.39 | -1.64 | -1.14 | -2.38 |
| AbCellera Biologics Inc. (ABCL)vs › | $4.03B | -0.54 | -0.52 | -0.25 | 0.00 |
| Edgewise Therapeutics, Inc. (EWTX)vs › | $4.25B | -1.85 | -1.54 | -1.48 | -1.19 |
| ICU Medical, Inc. (ICUI)vs › | $3.95B | 1.18 | -2.40 | -2.29 | -0.02 |
| Indivior Pharmaceuticals Inc (INDV)vs › | $4.38B | 2.79 | 0.85 | 0.10 | 0.11 |
| Heartflow, Inc. Common Stock (HTFL)vs › | $4.38B | -1.42 | -1.45 | -1.45 | -1.45 |
| Adaptive Biotechnologies Corporation (ADPT)vs › | $4.51B | -0.41 | -0.74 | -1.01 | -1.11 |
| Definium Therapeutics, Inc. (DFTX)vs › | $4.62B | -3.43 | -1.80 | -1.89 | -2.15 |
| LifeStance Health Group, Inc. (LFST)vs › | $4.64B | 0.13 | -0.06 | -0.31 | -0.46 |
| BillionToOne, Inc. (BLLN)vs › | $4.69B | 0.62 | -0.43 | -0.91 | -0.91 |
Trailing EPS (TTM)
$3.39
Forward EPS (Est.)
$4.36
P/E Ratio
22.1
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -4.45 |
| 2024-12-31 | 1.17 |
| 2023-12-31 | 0.33 |
| 2022-12-31 | -1.61 |
| 2021-12-31 | -2.68 |
| 2020-12-31 | -7.06 |
| 2019-12-31 | -3.22 |
| 2018-12-31 | -3.91 |
| 2017-12-31 | -0.52 |
| 2016-12-31 | -1.29 |
| 2015-04-30 | 2.19 |
| 2014-04-30 | 2.02 |
| 2013-04-30 | 1.68 |
| 2012-04-30 | 1.30 |
| 2011-04-30 | 1.67 |
| 2010-04-30 | 2.83 |
| 2009-04-30 | 1.00 |
| 2008-04-30 | -0.39 |
| 2007-04-30 | -2.01 |
| 2006-04-30 | -2.37 |
| 2005-04-30 | -0.51 |
| 2004-04-30 | 0.29 |
| 2003-04-30 | 0.24 |
| 2002-04-30 | -1.21 |
| 2000-06-30 | -0.17 |
| 1999-06-30 | -0.71 |
| 1998-06-30 | -0.88 |
| 1997-06-30 | -0.93 |
| 1996-06-30 | -1.06 |
| 1995-06-30 | -0.79 |
(FMP quote price / unrounded diluted TTM EPS) / five-year diluted EPS CAGR in percent, from annual statements through the period end shown Quote observation: 2026-10-06T14:38:18.549Z. Historical observations retain their original dates. Historical series through 2015-11-06.
